Panaro, Frank J.

Identification of ubiquitin ligases required for skeletal muscle atrophy.

Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science

Muscle Physiology and DisordersUbiquitin and proteasome pathways

Cited by 3,521

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.

Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell

Muscle Physiology and DisordersFOXO transcription factor regulation

Cited by 1,964

Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol

Kline, W. O., Panaro, F. J., Yang, H., & Bodine, S. C. (2007) · Journal of Applied Physiology

Muscle Physiology and DisordersPharmacological Effects and Assays

Cited by 177